Michael Frost

9.1k citations

66 papers · 3.2k indexed · 2 hit papers · h-index 21

Physiology top 1%
- Tuberous Sclerosis Complex Research 35
- Histiocytic Disorders and Treatments 4
Neurology top 5%
Psychiatry and Mental health top 5%
- Epilepsy research and treatment 8
Oncology top 5%
- Vascular Tumors and Angiosarcomas 4
- Polyomavirus and related diseases 4
Neurology top 5%
Pulmonary and Respiratory Medicine
- Renal cell carcinoma treatment 7
Public Health, Environmental and Occupational Health
- Opioid Use Disorder Treatment 7
Anesthesiology and Pain Medicine
- Pain Management and Opioid Use 4

Co-authors: Е. Д. Белоусова Petrus J. de Vries Gillian Turner Art Daniel John J. Bissler Gaurav Shah J.C. Kingswood Tarek Sahmoud
Cited by: Physiology Neurology Psychiatry and Mental health
Partner nations: United States Germany United Kingdom

In The Last Decade

Michael Frost

65 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
2012 Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Peers

Countries citing papers authored by Michael Frost

Since Specialization

Citations

This map shows the geographic impact of Michael Frost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Frost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Frost more than expected).

Fields of papers citing papers by Michael Frost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Frost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Frost. The network helps show where Michael Frost may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Frost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Frost Line = papers co-authored together Michael Frost links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial Michelle R. Lofwall,Edward V. Nunes,Sharon Walsh,Genie L. Bailey,Michael Frost,Natalie R. Budilovsky-Kelley,Elin Banke Nordbeck,Susanna Meyner,Peter Almgren,Stefan Peterson,Fredrik Tiberg	2025	1
2	Buprenorphine Implant Removal 7 Years Postinsertion: A Case Report Michael Frost,Raymond Bobb	2018	2
3	Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey Anne M. Rentz,Anne Skalicky,Zhimei Liu,David W. Dunn,Michael Frost,Jo Anne Nakagawa,Judith Prestifilippo,Qayyim Said,James W. Wheless	2018	3
4	Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related Angiomyolipomas Elyse Swallow,Sarah King,Jinlin Song,Miranda Peeples,James Signorovitch,Zhimei Liu,Judith Prestifilippo,Michael Frost,Michael Kohrman,Bruce R. Korf,Darcy A. Krueger,Steven Sparagana	2017	5
5	The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma John J. Bissler,David Neal Franz,Michael Frost,Е. Д. Белоусова,E. Martina Bebin,Steven Sparagana,Noah Berkowitz,Antonia Ridolfi,J.C. Kingswood	2017	28
6	Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study John J. Bissler,J.C. Kingswood,Elżbieta Radzikowska,Bernard A. Zonnenberg,Е. Д. Белоусова,Michael Frost,Matthias Sauter,Susanne Brakemeier,Petrus J. de Vries,Noah Berkowitz,Maurizio Voi,Séverine Peyrard,Klemens Budde	2017	99
7	Clinical management of tuberous sclerosis complex over the lifetime of a patient Michael Frost,John C. Hulbert	2015	7
8	Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial John J. Bissler,J.C. Kingswood,Elżbieta Radzikowska,Bernard A. Zonnenberg,Michael Frost,Е. Д. Белоусова,Matthias Sauter,Norio Nonomura,Susanne Brakemeier,Petrus J. de Vries,Noah Berkowitz,Sara Miao,Scott Segal,Séverine Peyrard,Klemens Budde	2015	111
9	PD35-10 EVEROLIMUS FOR RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: EFFICACY AND SAFETY AFTER 3.5 YEARS OF TREATMENT IN THE EXIST-2 STUDY John J. Bissler,J.C. Kingswood,Elżbieta Radzikowska,Bernard A. Zonnenberg,Michael Frost,Elena Belousova,Matthias Sauter,Norio Nonomura,Susanne Brakemeier,Petrus de Vries,Noah Berkowitz,Séverine Peyrard,Klemens Budde	2015	2
10	Everolimus Long-Term Efficacy and Safety for the Treatment of Subependymal Giant Cell Astrocytoma (SEGA) Associated With Tuberous Sclerosis Complex (TSC) (S42.007) David Neal Franz,Е. Д. Белоусова,Steven Sparagana,E. Martina Bebin,Michael Frost,Rachel Kuperman,Olaf Witt,Michael Kohrman,J. Robert Flamini,Joyce Y. Wu,Paolo Curatolo,Petrus de Vries,Noah Berkowitz,Oezlem Anak,Julie Niolat,Sergiusz Jóźwiak	2014	1
11	Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study David Neal Franz,Е. Д. Белоусова,Steven Sparagana,E. Martina Bebin,Michael Frost,Rachel Kuperman,Olaf Witt,Michael Kohrman,J. Robert Flamini,Joyce Y. Wu,Paolo Curatolo,Petrus J. de Vries,Noah Berkowitz,Oezlem Anak,Julie Niolat,Sergiusz Jóźwiak	2014	127
12	The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1 J.C. Kingswood,Sergiusz Jóźwiak,Е. Д. Белоусова,Michael Frost,Rachel Kuperman,E. Martina Bebin,Bruce R. Korf,J. Robert Flamini,Michael Kohrman,Steven Sparagana,Joyce Y. Wu,Thomas Brechenmacher,Karen Stein,Noah Berkowitz,John J. Bissler,David Neal Franz	2014	62
13	PD17-01 EVEROLIMUS FOR RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: EXIST-2 LONG-TERM EFFICACY AND SAFETY John J. Bissler,J.C. Kingswood,Elżbieta Radzikowska,Bernard A. Zonnenberg,Michael Frost,Matthias Sauter,Norio Nonomura,Susanne Brakemeier,Petrus J. de Vries,Scott Segal,Oezlem Anak,Severine Peyard,Klemens Budde	2014	1
14	Characteristics and Burden of Subependymal Giant Cell Astrocytomas (SEGAs) in Patients with Tuberous Sclerosis Complex: Results of a Patient and Caregiver Survey (P07.016) David Dunn,Anne M. Rentz,Anne Skalicky,Corey Pelletier,Zhimei Liu,Judith Prestifilippo,JoAnne Nakagawa,Michael Frost,James W. Wheless,Chris L. Pashos	2013	1
15	Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialbreakdown → John J. Bissler,J.C. Kingswood,Elżbieta Radzikowska,Bernard A. Zonnenberg,Michael Frost,Е. Д. Белоусова,Matthias Sauter,Norio Nonomura,Susanne Brakemeier,Petrus J. de Vries,Vicky Whittemore,David Chen,Tarek Sahmoud,Gaurav Shah,Jeremie Lincy,David Lebwohl,Klemens Budde	2013	629
16	Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialbreakdown → David Neal Franz,Е. Д. Белоусова,Steven Sparagana,E. Martina Bebin,Michael Frost,Rachel Kuperman,Olaf Witt,Michael Kohrman,J. Robert Flamini,Joyce Y. Wu,Paolo Curatolo,Petrus J. de Vries,Vicky Whittemore,Elizabeth A. Thiele,James Ford,Gaurav Shah,Helene Cauwel,David Lebwohl,Tarek Sahmoud,Sergiusz Jóźwiak	2012	578
17	Enhanced Epidermal Growth Factor, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor Expression in Tuberous Sclerosis Complex Whitney E. Parker,Ksenia Orlova,Gregory G. Heuer,Marianna Baybis,Eleonora Aronica,Michael Frost,Michael Wong,Peter B. Crino	2011	32
18	Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy James W. Wheless,Lionel Carmant,Martina Bebin,Joan A. Conry,Catherine Chiron,Roy D. Elterman,Michael Frost,Juliann Paolicchi,W. Donald Shields,Elizabeth A. Thiele,Mary L. Zupanc,Stephen D. Collins	2008	85
19	Nitrogen, Phosphorus, and Potassium Effects on Seeded Buffalograss Establishment Kevin W. Frank,Roch E. Gaussoin,Jack D. Fry,Michael Frost,James H. Baird	2002	14
20	Vagus Nerve Stimulation in Children with Refractory Seizures Associated with Lennox–Gastaut Syndrome Michael Frost,John R. Gates,Sandra L. Helmers,James W. Wheless,Paul M. Levisohn,Carmelo Tardo,Joan A. Conry	2001	185

About Michael Frost

Michael Frost is a scholar working on Physiology, Anesthesiology and Pain Medicine and Toxicology, having authored 66 papers that have together received 3.2k indexed citations. Recurring topics across this work include Tuberous Sclerosis Complex Research (35 papers), Epilepsy research and treatment (8 papers), Renal cell carcinoma treatment (7 papers), Opioid Use Disorder Treatment (7 papers), Vascular Tumors and Angiosarcomas (4 papers), Pain Management and Opioid Use (4 papers), Histiocytic Disorders and Treatments (4 papers) and Polyomavirus and related diseases (4 papers). The work is most often cited by research in Physiology (1.6k citations), Neurology (287 citations) and Psychiatry and Mental health (381 citations). Michael Frost has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Е. Д. Белоусова, Petrus J. de Vries, Gillian Turner, Art Daniel, John J. Bissler, Gaurav Shah, J.C. Kingswood, Tarek Sahmoud, David Lebwohl and Vicky Whittemore.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact